Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Anuja Abhyankar"'
Autor:
Vijay M. Patil, Arti Bhelekar, Nandini Menon, Atanu Bhattacharjee, Vijai Simha, Ram Abhinav, Anuja Abhyankar, Epari Sridhar, Abhishek Mahajan, Ameya D. Puranik, Nilendu Purandare, Amit Janu, Ankita Ahuja, Rahul Krishnatry, Tejpal Gupta, Rakesh Jalali
Publikováno v:
Cancer Medicine, Vol 9, Iss 13, Pp 4676-4685 (2020)
Abstract Background Relapsed high‐grade glioma has dismal outcomes. Mebendazole has shown promising activity against glioma in in‐vitro and in‐vivo studies. Hence, we undertook a phase 1 study to repurpose mebendazole in the treatment of gliobl
Externí odkaz:
https://doaj.org/article/d0d509fdcef449d0816d5a6561a55a02
Autor:
Vijay M Patil, Vanita Noronha, Amit Joshi, Vikas Talreja, Sachin Dhumal, Nandini Menon, Anuja Abhyankar, Hollis Dsouza, Gunjesh Kumar Singh, Atanu Bhattacharjee, Sarbani Ghosh-Laskar, Prathamesh Pai, Pankaj Chaturvedi, Deepa Nair, Devendra Chaukar, Anil DCruz, Prakash Shetty, Aliasgar Moiyadi, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 2, Pp 201-206 (2020)
Background: Sinonasal tumors are a rare group of neoplasms with limited data available regarding their treatment. Objectives: To estimate the 5 year outcomes and late adverse events of locally advanced sinonasal tumors treated with neoadjuvant therap
Externí odkaz:
https://doaj.org/article/07dd335bee11413bac3bfb538b22ea8f
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 158-162 (2019)
Background: Management of ovarian cancer has evolved over time with innovations in surgical management as well as in systemic therapy. In the real world, treatment is often adapted to distinct settings based on the socioeconomic factors, physician an
Externí odkaz:
https://doaj.org/article/5854ec882e414536bdf1b3f6919bccb6
Autor:
Vijay M Patil, Vanita Noronha, Amit Joshi, Anuja Abhyankar, Nandini Menon, Shripad Banavali, Sudeep Gupta, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 1, Pp 54-60 (2019)
Checkpoint inhibitors are versatile immunomodulatory agents, and they are being approved for the treatment of an increasing number of cancers, based on the demonstration of clinical benefits. While they have changed the landscape of treatment of many
Externí odkaz:
https://doaj.org/article/29a015d8aa3f4403bfbe010d45640696
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 2, Pp 339-340 (2020)
Externí odkaz:
https://doaj.org/article/d87ae04cdec94bc9bb33c97a5b2c5754
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:CLO22-032
Autor:
Kumar Prabhash, Jayita Deodhar, Anuja Abhyankar, Nandini Menon, Vijay Patil, Vanita Noronha, Pankaj Singhai, Naveen Salins, Atanu Bhattacharjee, Sachin Dhumal, Amit Joshi, Mary Ann Muckaden, Rupali Tambe, Ashwini Khake
Publikováno v:
J Natl Cancer Inst
Background Early palliative care (EPC) is an important aspect of cancer management but, to our knowledge, has never been evaluated in patients with head and neck cancer. Hence, we performed this study to determine whether the addition of EPC to stand
Publikováno v:
American Journal of Gastroenterology. 117:e2015-e2016
Publikováno v:
American Journal of Gastroenterology. 117:e730-e731
Autor:
Garvit Chhabra, Anuja Abhyankar, Michael Eiswerth, Freeha Khan, Robert Luckett, Gerald Dryden
Publikováno v:
American Journal of Gastroenterology. 117:e677-e678